Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Actually if they have more firms like Autifony Therapeutics Ltd in their portfolio then maybe IPO could take off at some point. They do have stakes in 30-40 firms.
Not sure if Invesco just wanted to go below 20% or are reducing still. I think they want to increase their cash position as investors could be demanding money back. They are in some trouble I think. Share price has been staying above 60p here.
At present value the other holdings need to be worth 390m to match the 60p share price. So could still be fair value even at these prices. I don't have time to dig into the accounts of every firm. Even then I don't know their 2019 performance.
Blimey, how to depress me..............thanks.
A well researched reality check mind, I hadn't looked into it much...............like Jurado i own a few others like XSG and AVCT so incurring some pain.
Interesting to see Invesco reduce their holding further to under 20% now. I wonder if they will continue to decrease - they are under some pressure to reduce exposure to small caps, following the Woodford fiasco. With this cloud lingering, I can see the SP being subdued for a while.
I just hope we don't have a hung parliament and more uncertainty
Sounds like you are taking some big losses here.
Since start of year,
Xeros down 95%. Lost 19p. Now at 1p. Was 10p in June
MWG Down 85%. - 8p to 1.2p. 4p or so in June.
TRX Down 80% 6.5p-1.1p
There must be value in these other firms as IP Group rated their portfolio worth 1.1bn. Where does that other 800m come from? I fail to see it. Private firms must be doing okay. These 1p shares will struggle to recover. MWG had divisions which were close to going under.
Seems to have been some very risky investments here which simply have not paid off.
https://www.ipgroupplc.com/our-portfolio/portfolio
They list their top 20 portfolio companies by value.
Yoyo Wallets lost 4.1m on year albeit revenue up 120% to 3.6m. They have about 10m in cash.
Wave Optics lost 10m in 2018. They have just done a fund raise. I hope they have a plan. Turnover 1.3m.
Actual experience down 50% on year now 110p.
Autifony Therapeutics Ltd - Seems to of done well in 2018 with profits of 16m. Revenue 22 compared to 600k last year.
Cell Medica Ltd - Revenue not great and seems to be losing money.
Problem with these above is that the accounts don't show how 2019 is going. Only year end 2018. You can look up each Beta Company results online using a search engine. There are 16 or so other firms I could look through in the top 20. Plus many many more outside this. People in the industry would know better.
Goodness knows I takes your point about poor performance elsewhere - I own most of them too. I suppose my faint optimism is that TRX, XSG and MWG barely have any further to fall, while the scale of growth at Nanopore could be huge. Of course the more serious analysts will be more aware of the progress in the unlisted companies and how many have serious potential - First Light Fusion seems like science fiction to me, but it were to happen then surely the impact would be astonishing.
Interestingly they put a value on their stake of 274m. It's not a huge rise today. Share does seem to be edging higher.
The rest of their PLC shares you can search on here are doing terrible. Apart from Ceres and one other that is marginally higher than it was in August, Many are down 50-90% on the year. Question is are their other investments making up for these losses? On paper their assets are supposedly worth just over 1bn. So in effect they are at a 40% discount. If they tried to sell some of these the shares might collapse. Others could be almost worthless.
It almost feels like everything depends on this one company. Least there is some value here. Be interesting to see the full figures next year. They won't look pretty as they have taken some losses this year on their smaller investments.
Can't pretend to understand the full impact of today rns re Oxford Nanopore, but as by some distance the biggest item in our portfolio the future of Oxford Nanopore is vital to IPO and I get the feeling it really is starting to hit paydirt. Doubled it's revenues last year and this seems to be a major step forward. In any portfolio of our size there will be plenty of losers but the progress here - as well as at Ceres - is reason enough to be optimistic that that paper figures should improve considerably. Whether that translates to shareholder value is far from certain but I think this could be an exciting year coming up. If anyone can offer informed view on how significant the Abu Dhabi deal could be I'd love to hear it.